Literature DB >> 12084888

Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening.

Robert Forget1, Viorika Tozlovanu, Andreea Iancu, Dan Boghen.   

Abstract

Lid movement and EMG of the orbicularis oculi (OOc) were analyzed in 10 patients with apraxia of lid opening associated with blepharospasm before and after botulinum toxin treatment. The latencies to onset and to complete the eye opening and the time during which eye opening was sustained were studied in relation to OOc activity and compared with control values obtained in 12 healthy subjects. Following treatment there was an improvement of all lid opening measurements, a decrease of the abnormally prolonged OOc activity, and a reduction of the functional disability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084888     DOI: 10.1212/wnl.58.12.1843

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Noncosmetic periocular therapeutic applications of botulinum toxin.

Authors:  Pelin Kaynak-Hekimhan
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

Review 2.  Primary blepharospasm: diagnosis and management.

Authors:  Giovanni Defazio; Paolo Livrea
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment.

Authors:  Giovanni Fabbrini; Giovanni Defazio; Carlo Colosimo; Philip D Thompson; Alfredo Berardelli
Journal:  Nat Clin Pract Neurol       Date:  2009-02

Review 4.  Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.

Authors:  Wolfgang H Jost
Journal:  Toxins (Basel)       Date:  2021-01-25       Impact factor: 4.546

5.  Blink index as a response predictor of blepharospasm to botulinum neurotoxin-A treatment.

Authors:  Jeongkyeong Jang; Helen Lew
Journal:  Brain Behav       Date:  2021-09-23       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.